Stock Expert AI

HIMS

Hims & Hers Health, Inc.

$34.71 +1.30 (+3.89%)

1-Minute Take

TL;DR: Hims & Hers Health, Inc. operates a telehealth platform, providing direct-to-consumer access to healthcare professionals and a range of health and wellness products. The company leverages technology to offer.
What Matters:
  • Ongoing: Continued expansion of product offerings and services.
  • Ongoing: Increasing adoption of telehealth among consumers.
  • Upcoming: Potential partnerships with major healthcare providers.
Key Risks:
  • Potential: Changes in regulations governing telehealth and online prescriptions.
  • Potential: Increased competition from other telehealth providers.
What to Watch:
  • Next earnings report and guidance
  • Analyst consensus and price targets
Medium Confidence Based on verified company data and analysis

Data sources: market data, fundamentals, news providers. Data may be delayed.

Company Overview

Key Statistics

Volume
17271690
Market Cap
7610892627
MoonshotScore
58.0/100
FOMO Score
6.0

MoonshotScore Breakdown: 58.0/100

Revenue Growth
8/100 69.3%
Gross Margin
10/100 75.0%
Operating Leverage
6/100 Positive
Cash Runway
8/100 $221M
R&D Intensity
5/100 5.3%
Insider Activity
3/100 -$0.14M
Short Interest
3/100 16.18%
Price Momentum
2/100 Oversold RSI
News Sentiment
5/100 N/A

📰 Latest News

These Stocks Are Today’s Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More

Barrons.com 1 day ago

How Ozempic Brought a Napster Moment to Big Pharma

The Wall Street Journal 6 days ago

How Ozempic Brought a Napster Moment to Big Pharma

Yahoo! Finance: HIMS News 6 days ago

Weekend Morning Brew: AI Jitters, Novo--Hims Clash, McDonald's Beat

gurufocus.com 6 days ago

Hims & Hers Health is revolutionizing healthcare access with its multi-specialty telehealth platform, offering personalized wellness solutions and prescription medications directly to consumers. With a strong focus on convenience and affordability, HIMS is poised to capitalize on the growing demand for digital health services and expand its market share.

About HIMS

Hims & Hers Health, Inc. operates a telehealth platform, providing direct-to-consumer access to healthcare professionals and a range of health and wellness products. The company leverages technology to offer personalized and convenient healthcare solutions.

📊 Healthcare 🏢 Medical - Equipment & Services
CEO: Andrew Dudum HQ: San Francisco, CA, US Employees: 1637 Founded: 2019

Hims & Hers Health, Inc. Company Overview

Founded in 2017, Hims & Hers Health, Inc. emerged with a vision to transform the healthcare landscape by providing accessible and convenient solutions for everyday health needs. Recognizing the challenges individuals face in accessing traditional healthcare, the company pioneered a direct-to-consumer telehealth platform that connects users with licensed healthcare professionals. Initially focused on addressing stigmatized conditions like hair loss and erectile dysfunction, Hims & Hers has expanded its offerings to encompass a comprehensive range of health and wellness categories, including skincare, mental health, and primary care. The company's evolution has been marked by a commitment to innovation and customer-centricity, leveraging technology to deliver personalized and affordable healthcare solutions. Today, Hims & Hers operates a robust platform that offers prescription medication, over-the-counter products, and ongoing care from healthcare providers. With a strong emphasis on discretion and convenience, the company has cultivated a loyal customer base and established itself as a leader in the rapidly growing telehealth market. Hims & Hers continues to expand its product offerings and services, solidifying its position as a comprehensive digital health destination. The company's headquarters are located in San Francisco, California, and it serves customers across the United States.

Investment Thesis

Hims & Hers Health presents a compelling investment opportunity due to its strong growth trajectory and disruptive business model. The company's direct-to-consumer telehealth platform is capitalizing on the increasing demand for convenient and affordable healthcare solutions. With a gross margin of 75.0% and a focus on recurring revenue through subscription-based prescription services, Hims & Hers is demonstrating strong financial performance. The company's ability to expand its product offerings and attract new customers through targeted marketing campaigns positions it for continued growth. Furthermore, the increasing acceptance of telehealth and the company's strategic partnerships with wholesale partners create significant opportunities for market expansion. The company's P/E ratio is 38.95, reflecting investor confidence in its future earnings potential. As Hims & Hers continues to innovate and scale its platform, it is poised to deliver significant value to shareholders.

Key Financial Highlights

  • Market Cap of $5.05B reflects strong investor confidence in the company's growth potential.
  • Gross Margin of 75.0% indicates efficient operations and strong pricing power.
  • P/E ratio of 38.95 suggests investors are willing to pay a premium for HIMS's earnings, anticipating future growth.
  • The company operates a multi-specialty telehealth platform, offering a wide range of services and products.
  • Hims & Hers connects consumers directly to licensed healthcare professionals, providing convenient and accessible care.

Industry Context

The telehealth industry is experiencing rapid growth, driven by increasing demand for convenient and affordable healthcare solutions. The market is characterized by intense competition, with companies vying for market share by offering innovative services and products. Hims & Hers Health is well-positioned to capitalize on this trend, leveraging its direct-to-consumer platform and comprehensive range of health and wellness offerings. The company faces competition from established healthcare providers and other telehealth companies, but its focus on personalized care and discreet service provides a competitive edge. The telehealth market is projected to continue its growth trajectory, creating significant opportunities for Hims & Hers to expand its market share and solidify its position as a leader in the industry.

Quarterly Financial Summary

Quarter Revenue Net Income EPS
Q3 2025 $599M $16M $0.06
Q2 2025 $545M $43M $0.17
Q1 2025 $586M $49M $0.20
Q4 2024 $481M $26M $0.11

Source: Company filings. Data may be delayed.

Growth Opportunities

  • Expansion into New Markets: Hims & Hers has the opportunity to expand its services into new geographic markets, both domestically and internationally. By leveraging its telehealth platform and marketing expertise, the company can reach a wider customer base and drive revenue growth. The global telehealth market is projected to reach $55.6 billion by 2027, representing a significant opportunity for Hims & Hers to expand its reach and capture market share. Timeline: Ongoing.
  • Introduction of New Product Lines: Hims & Hers can further expand its product offerings to address a wider range of health and wellness needs. By introducing new product lines, such as chronic disease management programs or specialized skincare solutions, the company can attract new customers and increase revenue per user. The market for personalized health and wellness products is growing rapidly, driven by increasing consumer awareness and demand for customized solutions. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: Hims & Hers can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. By partnering with established healthcare providers or acquiring complementary telehealth companies, Hims & Hers can accelerate its growth and enhance its competitive position. The market for telehealth acquisitions is active, with companies seeking to consolidate their market share and expand their service offerings. Timeline: Ongoing.
  • Enhancement of Technology Platform: Hims & Hers can continue to invest in its technology platform to improve the user experience and enhance its service offerings. By incorporating new features, such as AI-powered personalized recommendations or virtual reality-based therapy programs, the company can differentiate itself from competitors and attract new customers. The market for telehealth technology is constantly evolving, with new innovations emerging regularly. Timeline: Ongoing.
  • Increased Focus on Mental Health Services: Hims & Hers can capitalize on the growing demand for mental health services by expanding its offerings in this area. By providing access to licensed therapists and offering personalized mental health programs, the company can address a critical unmet need and drive revenue growth. The market for mental health services is experiencing significant growth, driven by increasing awareness and acceptance of mental health issues. Timeline: Ongoing.

Competitive Advantages

  • Brand Recognition: Strong brand recognition and reputation in the direct-to-consumer telehealth market.
  • Proprietary Technology Platform: User-friendly and scalable telehealth platform that connects consumers with healthcare professionals.
  • Subscription-Based Revenue Model: Recurring revenue stream from prescription medications and ongoing care.
  • Data and Personalization: Ability to leverage data to personalize treatment plans and product recommendations.

Strengths

  • Strong brand recognition and reputation.
  • Proprietary telehealth platform.
  • Subscription-based revenue model.
  • Direct-to-consumer approach.

Weaknesses

  • Reliance on marketing spend for customer acquisition.
  • Limited physical presence.
  • Regulatory risks associated with telehealth and prescription medications.
  • Competition from established healthcare providers and other telehealth companies.

Opportunities

  • Expansion into new markets and product lines.
  • Strategic partnerships and acquisitions.
  • Increased focus on mental health services.
  • Enhancement of technology platform.

Threats

  • Changes in telehealth regulations.
  • Increased competition from new entrants.
  • Data security and privacy breaches.
  • Negative publicity or product recalls.

What HIMS Does

  • Connect consumers with licensed healthcare professionals through a telehealth platform.
  • Offer prescription medication for various health conditions.
  • Provide over-the-counter drug and device products.
  • Offer cosmetics and supplement products.
  • Focus on wellness, sexual health, skincare, and hair care.
  • Provide medical consultation services.
  • Offer health and wellness products through wholesale partners.

Business Model

  • Direct-to-consumer sales of prescription and non-prescription products through their website and mobile app.
  • Subscription-based recurring revenue for prescription medications and ongoing care.
  • Revenue from medical consultation services provided by licensed healthcare professionals.
  • Wholesale partnerships to distribute health and wellness products through other retailers.

Key Customers

  • Individuals seeking convenient and affordable access to healthcare.
  • Consumers looking for solutions to address specific health conditions, such as hair loss, erectile dysfunction, and skincare concerns.
  • People seeking personalized health and wellness products and services.
  • Customers who value discretion and privacy in their healthcare experience.

Competitors

  • Align Technology (ALGN): Focuses on clear aligner therapy and digital orthodontics.
  • Baxter International (BAX): Offers a broad portfolio of medical products and services, including dialysis and hospital products.
  • BioMarin Pharmaceutical (BMRN): Develops and commercializes therapies for rare genetic diseases.
  • Ensign Group (ENSG): Provides skilled nursing, rehabilitative care, and other healthcare services.
  • HealthEquity (HQY): Provides health savings accounts and other consumer-directed benefits.

Catalysts

  • Ongoing: Continued expansion of product offerings and services.
  • Ongoing: Increasing adoption of telehealth among consumers.
  • Upcoming: Potential partnerships with major healthcare providers.
  • Ongoing: Strategic marketing initiatives to drive customer acquisition.

Risks

  • Potential: Changes in regulations governing telehealth and online prescriptions.
  • Potential: Increased competition from other telehealth providers.
  • Ongoing: Reliance on third-party suppliers for products and medications.
  • Potential: Data security breaches and privacy concerns.
  • Ongoing: High marketing expenses impacting profitability.

FAQ

What does Hims & Hers Health, Inc. (HIMS) do?

Hims & Hers Health, Inc. operates a telehealth platform, providing direct-to-consumer access to healthcare professionals and a range of health and wellness products. The company leverages technology to offer personalized and convenient healthcare solutions.

Why does HIMS move today?

HIMS is up 3.89% today. Stock prices move due to earnings, news, market sentiment, and sector trends. Check the News tab for recent developments.

What are the biggest risks for HIMS?

Potential: Changes in regulations governing telehealth and online prescriptions.. Potential: Increased competition from other telehealth providers.

How should beginners use this page?

Start with the 1-Minute Take for a quick summary. Review Key Statistics for fundamentals. Check the News tab for recent developments. Use our Portfolio Tracker to practice without real money. Never invest more than you can afford to lose.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Related Stocks in Medical - Equipment & Services

Browse More

Next Steps

Data provided for informational purposes only. View more at Stock Expert AI

Last updated: 2026-02-20T21:02:59.357Z